Zillion announced today its partnership with Dexcom, the leader in real-time continuous glucose monitoring (CGM), to connect Dexcom CGM with Zillion’s platform for use with their RestoreHealth program. This partnership will continue to enhance the RestoreHealth offering to employer and health system patients.
“Type 2 Diabetes continues to be a growing health problem. At Zillion, our goal is to develop programs to improve individual health outcomes, as well as reduce medical expenses”, “We’re excited to partner with Dexcom to provide patients with the data they need to take control of their health and experience real improvements that help them live happier and healthier lives.”
Zillion President and CEO, Cheryl Morrison Deutsch
Statistics show that people with diabetes have two-to-three times higher medical expenses. Although they represent 10-15% of the total patient population, they represent 30-50% of total medical and pharmacy expenditures each year.
“CGM represents a technological improvement that helps RestoreHealth members and coaches proactively manage real-time health data to allow for adjustments to the plan of care.”
“We have seen metabolic disease factor reduction with RestoreHealth”, “In some cases we have been able to successfully decrease disease incidence. We expect to see significant enhancement to these results with this partnership.”
Dr. Cate Collings, Chief Medical Officer for Zillion
Today, thousands of members across multiple programs powered by Zillion are experiencing healthier lives. Zillion has delivered programs for Fortune 500 companies that include national health care payers, large health care providers, and US enterprises with a global footprint.
